C9orf72-FTD/ALS pathogenesis: evidence from human neuropathological studies
- 27 October 2018
- journal article
- review article
- Published by Springer Nature in Acta Neuropathologica
- Vol. 137 (1) , 1-26
Abstract
What are the most important and treatable pathogenic mechanisms in C9orf72-FTD/ALS? Model-based efforts to address this question are forging ahead at a blistering pace, often with conflicting results. But what does the human neuropathological literature reveal? Here, we provide a critical review of the human studies to date, seeking to highlight key gaps or uncertainties in our knowledge. First, we engage the C9orf72-specific mechanisms, including C9orf72 haploinsufficiency, repeat RNA foci, and dipeptide repeat protein inclusions. We then turn to some of the most prominent C9orf72-associated features, such as TDP-43 loss-of-function, TDP-43 aggregation, and nuclear transport defects. Finally, we review potential disease-modifying epigenetic and genetic factors and the natural history of the disease across the lifespan. Throughout, we emphasize the importance of anatomical precision when studying how candidate mechanisms relate to neuronal, regional, and behavioral findings. We further highlight methodological approaches that may help address lingering knowledge gaps and uncertainties, as well as other logical next steps for the field. We conclude that anatomically oriented human neuropathological studies have a critical role to play in guiding this fast-moving field toward effective new therapies.Keywords
Funding Information
- National Institute on Aging (AG023501, AG019724, AG033017)
- The Bluefield Project to Cure FTD
- Tau Consortium
This publication has 175 references indexed in Scilit:
- TDP‐43 and FUS en route from the nucleus to the cytoplasmFEBS Letters, 2017
- Clinical Evidence of Disease Anticipation in Families Segregating a C9orf72 Repeat ExpansionJAMA Neurology, 2017
- Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansionsAnnals of Neurology, 2016
- Cortical Function in Asymptomatic Carriers and Patients WithC9orf72Amyotrophic Lateral SclerosisJAMA Neurology, 2015
- Isoform‐specific antibodies reveal distinct subcellular localizations of C9orf72 in amyotrophic lateral sclerosisAnnals of Neurology, 2015
- Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosisAnnals of Neurology, 2013
- Investigation of C9orf72 in 4 Neurodegenerative DisordersArchives of Neurology, 2012
- C9ORF72 Repeat Expansion in Amyotrophic Lateral Sclerosis in the Kii Peninsula of JapanArchives of Neurology, 2012
- Frontal Paralimbic Network Atrophy in Very Mild Behavioral Variant Frontotemporal DementiaArchives of Neurology, 2008
- Early frontotemporal dementia targets neurons unique to apes and humansAnnals of Neurology, 2006